Hyderabad’s Gland Pharma to make 252 million doses of Sputnik V

Gland Pharma, based out of Hyderabad, has entered into an agreement with Russian Direct Investment Fund (RDIF), a sovereign wealth fund, to manufacture and supply 252 million (25.2 crore) doses of the Russian Covid-19 vaccine Sputnik V.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3rYsSuj